CD79A and shigellosis: Furthermore, IgA mAb against chlamydial major outer membrane protein confers passive protection in mice [26], and likewise, IgA mAb protects against murine experimental shigellosis [27] and oral challenge of the invasive Salmonella typhimurium [18].